96 related articles for article (PubMed ID: 19062721)
21. Expression of class III beta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancer.
Koh Y; Jang B; Han SW; Kim TM; Oh DY; Lee SH; Kang CH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Kim YW; Kim JH; Heo DS; Bang YJ
J Thorac Oncol; 2010 Mar; 5(3):320-5. PubMed ID: 20087230
[TBL] [Abstract][Full Text] [Related]
22. Heat shock protein 70 as a predictive marker for platinum-based adjuvant chemotherapy in patients with resected non-small cell lung cancer.
Park TS; Kim HR; Koh JS; Jang SH; Hwang YI; Yoon HI; Chung JH; Kim CH; Kim SS; Kim WS; Jo J; Lee JC; Choi CM
Lung Cancer; 2014 Nov; 86(2):262-7. PubMed ID: 25261232
[TBL] [Abstract][Full Text] [Related]
23. Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology.
Jeong SH; Lee HW; Han JH; Kang SY; Choi JH; Jung YM; Choi H; Oh YT; Park KJ; Hwang SC; Sheen SS; Oh YJ; Kim JH; Lim HY
Jpn J Clin Oncol; 2008 Oct; 38(10):661-9. PubMed ID: 18772168
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
Cho HJ; Kim HR; Park YS; Kim YH; Kim DK; Park SI
Surg Oncol; 2015 Dec; 24(4):329-34. PubMed ID: 26690822
[TBL] [Abstract][Full Text] [Related]
25. [The expression and prognostic significance of ERCC1 and GST-pi in lung cancer].
Xu C; Feng D; Li L; Yu P; Hu X; Liu Y
Zhongguo Fei Ai Za Zhi; 2010 Mar; 13(3):195-200. PubMed ID: 20673515
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
Chen P; Li J; Ge LP; Dai CH; Li XQ
Respirology; 2010 Apr; 15(3):501-9. PubMed ID: 20210890
[TBL] [Abstract][Full Text] [Related]
27. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy.
Li Z; Qing Y; Guan W; Li M; Peng Y; Zhang S; Xiong Y; Wang D
Cancer Chemother Pharmacol; 2014 Oct; 74(4):777-86. PubMed ID: 25107571
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Vansteenkiste JF; Cho BC; Vanakesa T; De Pas T; Zielinski M; Kim MS; Jassem J; Yoshimura M; Dahabreh J; Nakayama H; Havel L; Kondo H; Mitsudomi T; Zarogoulidis K; Gladkov OA; Udud K; Tada H; Hoffman H; Bugge A; Taylor P; Gonzalez EE; Liao ML; He J; Pujol JL; Louahed J; Debois M; Brichard V; Debruyne C; Therasse P; Altorki N
Lancet Oncol; 2016 Jun; 17(6):822-835. PubMed ID: 27132212
[TBL] [Abstract][Full Text] [Related]
30. The prognostic significance of ERCC1, BRCA1, XRCC1, and betaIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection.
Kang CH; Jang BG; Kim DW; Chung DH; Kim YT; Jheon S; Sung SW; Kim JH
Lung Cancer; 2010 Jun; 68(3):478-83. PubMed ID: 19683826
[TBL] [Abstract][Full Text] [Related]
31. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
[TBL] [Abstract][Full Text] [Related]
32. [Expression and prognostic value of survivin protein in early-stage non-small cell lung cancer].
Zhu ZH; Yang H; Fu JH; Hu Y; Ma Y; Wu QL; Rong TH; Wang DF
Ai Zheng; 2007 Nov; 26(11):1268-71. PubMed ID: 17991331
[TBL] [Abstract][Full Text] [Related]
33. [Expression of survivin and proliferating cell nuclear antigen in human non-small cell lung cancer].
Zhou JM; Zhou JH; Deng ZH; Zheng H; Jiang HY; Cao HQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):544-8. PubMed ID: 16320585
[TBL] [Abstract][Full Text] [Related]
34. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2].
Han PH; Li XJ; Qin H; Yao J; DU N; Ren H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395
[TBL] [Abstract][Full Text] [Related]
35. [Expression of ERCC1 mRNA and its impact on the prognosis of patients with non-small cell lung cancer].
Ma W; Li W; Gao M; Li XN
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):371-4. PubMed ID: 21875468
[TBL] [Abstract][Full Text] [Related]
36. Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications.
Mohamed S; Yasufuku K; Nakajima T; Hiroshima K; Chiyo M; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Agamy G; El-Shahhat H; Fujisawa T; Yoshino I
Eur Respir J; 2009 Jan; 33(1):127-33. PubMed ID: 18715879
[TBL] [Abstract][Full Text] [Related]
37. Expression of Elf-1 and survivin in non-small cell lung cancer and their relationship to intratumoral microvessel density.
Yang DX; Li NE; Ma Y; Han YC; Shi Y
Chin J Cancer; 2010 Apr; 29(4):396-402. PubMed ID: 20346215
[TBL] [Abstract][Full Text] [Related]
38. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.
Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Pilecka I; Jabłonka A
Folia Histochem Cytobiol; 2005; 43(4):237-42. PubMed ID: 16382892
[TBL] [Abstract][Full Text] [Related]
39. Expression of Bcl-2 predicts outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapy.
Jeong SH; Jung JH; Han JH; Kim JH; Choi YW; Lee HW; Kang SY; Hwang YH; Ahn MS; Choi JH; Oh YT; Chun M; Kang S; Park KJ; Hwang SC; Sheen SS
Lung Cancer; 2010 May; 68(2):288-94. PubMed ID: 19560836
[TBL] [Abstract][Full Text] [Related]
40. Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer.
Yan S; Shun-Chang J; Li C; Jie L; Ya-Li L; Ling-Xiong W
BMC Cancer; 2010 Nov; 10():621. PubMed ID: 21067592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
